Clinical Trial Update: Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial update on LBH589B for adult multiple myeloma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• LBH589B

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2021-07-14